These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21356291

  • 1. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS, Lu Q, Li W, Chen Y.
    Int J Pharm; 2011 Sep 15; 416(1):16-24. PubMed ID: 21356291
    [Abstract] [Full Text] [Related]

  • 2. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K.
    Int J Pharm; 2010 Feb 15; 386(1-2):30-41. PubMed ID: 19900518
    [Abstract] [Full Text] [Related]

  • 3. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C, Khela MK, Evans DF, Jones BE, Nagata S, Basit AW.
    Eur J Pharm Sci; 2007 Mar 15; 30(3-4):251-5. PubMed ID: 17188473
    [Abstract] [Full Text] [Related]

  • 4. "Performance qualification of a new hypromellose capsule. Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules and Part II. Disintegration and dissolution comparison between two types of hypromellose capsules" by M. Sherry Ku et al.
    Jones BE, Podczeck F.
    Int J Pharm; 2012 Feb 28; 423(2):589-92. PubMed ID: 22155286
    [No Abstract] [Full Text] [Related]

  • 5. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Feb 28; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 6. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 Feb 28; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 7. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM.
    Int J Pharm; 2011 Oct 31; 419(1-2):192-9. PubMed ID: 21843611
    [Abstract] [Full Text] [Related]

  • 8. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y, Nazzal S, Bottom CB.
    Drug Dev Ind Pharm; 2007 Jan 31; 33(1):27-34. PubMed ID: 17192248
    [Abstract] [Full Text] [Related]

  • 9. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F, Jones BE.
    Drug Dev Ind Pharm; 2002 Oct 31; 28(9):1163-9. PubMed ID: 12455475
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET, Scott RA, Cade D, Connor AL, Wilding IR.
    Pharm Res; 2004 May 31; 21(5):793-8. PubMed ID: 15180336
    [Abstract] [Full Text] [Related]

  • 11. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR, Choi JS, Liu Y, Xu WJ, Yang M, Lee BJ, Cui JH.
    Drug Dev Ind Pharm; 2013 Nov 31; 39(11):1720-30. PubMed ID: 23062115
    [Abstract] [Full Text] [Related]

  • 12. The shell dissolution of various empty hard capsules.
    Chiwele I, Jones BE, Podczeck F.
    Chem Pharm Bull (Tokyo); 2000 Jul 31; 48(7):951-6. PubMed ID: 10923822
    [Abstract] [Full Text] [Related]

  • 13. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.
    Jones BE, Basit AW, Tuleu C.
    Int J Pharm; 2012 Mar 15; 424(1-2):40-3. PubMed ID: 22214655
    [Abstract] [Full Text] [Related]

  • 14. The use of hypromellose in oral drug delivery.
    Li CL, Martini LG, Ford JL, Roberts M.
    J Pharm Pharmacol; 2005 May 15; 57(5):533-46. PubMed ID: 15901342
    [Abstract] [Full Text] [Related]

  • 15. HPMC capsules: current status and future prospects.
    Al-Tabakha MM.
    J Pharm Pharm Sci; 2010 May 15; 13(3):428-42. PubMed ID: 21092714
    [Abstract] [Full Text] [Related]

  • 16. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
    Curatolo W, Liu P, Johnson BA, Hausberger A, Quan E, Vendola T, Vatsaraj N, Foulds G, Vincent J, Chandra R.
    Pharm Res; 2011 Jul 15; 28(7):1531-9. PubMed ID: 21331473
    [Abstract] [Full Text] [Related]

  • 17. Evaluation and comparison of physicomechanical characteristics of gelatin and hypromellose capsules.
    Missaghi S, Fassihi R.
    Drug Dev Ind Pharm; 2006 Aug 15; 32(7):829-38. PubMed ID: 16908420
    [Abstract] [Full Text] [Related]

  • 18. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC, da Silva C, Bresolin TM, Serra CH, Porta V.
    Int J Pharm; 2010 Feb 15; 386(1-2):201-7. PubMed ID: 19941944
    [Abstract] [Full Text] [Related]

  • 19. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M, Rothenhäusler B, Röthlisberger D.
    Drug Dev Ind Pharm; 2006 Feb 15; 32(10):1165-73. PubMed ID: 17090439
    [Abstract] [Full Text] [Related]

  • 20. Capsule shell material impacts the in vitro disintegration and dissolution behaviour of a green tea extract.
    Glube N, Moos Lv, Duchateau G.
    Results Pharma Sci; 2013 Feb 15; 3():1-6. PubMed ID: 25755998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.